Somatostatinski receptor tip 2 je protein koji je kod čoveka kodiran SSTR2genom..[1]
Somatostatin deluje na mnogim lokacijama i inhibira oslobađanje hormona i drugih sekretornih proteina. Biološki efekti somatostatina su posredovani familijom G protein-spregnutih receptora čije izražavanje je specifično za pojedina tkiva. SSTR2 u znatnoj meri izražen u velikom mozgu i bubrezima.[2]
↑Yamada Y, Stoffel M, Espinosa R 3rd, Xiang KS, Seino M, Seino S, Le Beau MM, Bell GI (Apr 1993). „Human somatostatin receptor genes: localization to human chromosomes 14, 17, and 22 and identification of simple tandem repeat polymorphisms”. Genomics15 (2): 449–52. DOI:10.1006/geno.1993.1088. PMID8449518.
↑Zitzer, H; Hönck H H, Bächner D, Richter D, Kreienkamp H J (Nov 1999). „Somatostatin receptor interacting protein defines a novel family of multidomain proteins present in human and rodent brain”. J. Biol. Chem. (UNITED STATES) 274 (46): 32997–3001. DOI:10.1074/jbc.274.46.32997. ISSN0021-9258. PMID10551867.
Reubi JC, Waser B, Schaer JC, Markwalder R (1995). „Somatostatin receptors in human prostate and prostate cancer.”. J. Clin. Endocrinol. Metab.80 (9): 2806–14. DOI:10.1210/jc.80.9.2806. PMID7673428.
Kagimoto S, Yamada Y, Kubota A, et al. (1994). „Human somatostatin receptor, SSTR2, is coupled to adenylyl cyclase in the presence of Gi alpha 1 protein.”. Biochem. Biophys. Res. Commun.202 (2): 1188–95. DOI:10.1006/bbrc.1994.2054. PMID7914078.
Patel YC, Greenwood M, Kent G, et al. (1993). „Multiple gene transcripts of the somatostatin receptor SSTR2: tissue selective distribution and cAMP regulation.”. Biochem. Biophys. Res. Commun.192 (1): 288–94. DOI:10.1006/bbrc.1993.1412. PMID8386508.
Fukusumi S, Kitada C, Takekawa S, et al. (1997). „Identification and characterization of a novel human cortistatin-like peptide.”. Biochem. Biophys. Res. Commun.232 (1): 157–63. DOI:10.1006/bbrc.1997.6252. PMID9125122.
Jaïs P, Terris B, Ruszniewski P, et al. (1997). „Somatostatin receptor subtype gene expression in human endocrine gastroentero-pancreatic tumours.”. Eur. J. Clin. Invest.27 (8): 639–44. DOI:10.1046/j.1365-2362.1997.1740719.x. PMID9279525.
Lopez F, Estève JP, Buscail L, et al. (1997). „The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling.”. J. Biol. Chem.272 (39): 24448–54. DOI:10.1074/jbc.272.39.24448. PMID9305905.
Tsutsumi A, Takano H, Ichikawa K, et al. (1997). „Expression of somatostatin receptor subtype 2 mRNA in human lymphoid cells.”. Cell. Immunol.181 (1): 44–9. DOI:10.1006/cimm.1997.1193. PMID9344495.
Sharma K, Patel YC, Srikant CB (1999). „C-terminal region of human somatostatin receptor 5 is required for induction of Rb and G1 cell cycle arrest.”. Mol. Endocrinol.13 (1): 82–90. DOI:10.1210/me.13.1.82. PMID9892014.
Zitzer H, Richter D, Kreienkamp HJ (1999). „Agonist-dependent interaction of the rat somatostatin receptor subtype 2 with cortactin-binding protein 1.”. J. Biol. Chem.274 (26): 18153–6. DOI:10.1074/jbc.274.26.18153. PMID10373412.
Zitzer H, Hönck HH, Bächner D, et al. (2000). „Somatostatin receptor interacting protein defines a novel family of multidomain proteins present in human and rodent brain.”. J. Biol. Chem.274 (46): 32997–3001. DOI:10.1074/jbc.274.46.32997. PMID10551867.
Petersenn S, Rasch AC, Presch S, et al. (2000). „Genomic structure and transcriptional regulation of the human somatostatin receptor type 2.”. Mol. Cell. Endocrinol.157 (1-2): 75–85. DOI:10.1016/S0303-7207(99)00161-6. PMID10619399.
Kreienkamp HJ, Zitzer H, Richter D (2001). „Identification of proteins interacting with the rat somatostatin receptor subtype 2.”. J. Physiol. Paris94 (3-4): 193–8. DOI:10.1016/S0928-4257(00)00204-7. PMID11087996.
Zatelli MC, Tagliati F, Taylor JE, et al. (2001). „Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line tt.”. J. Clin. Endocrinol. Metab.86 (5): 2161–9. DOI:10.1210/jc.86.5.2161. PMID11344221.